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African swine fever virus (ASFV) growth and plaque formation were inhibited by phosphonoacetic acid (PAA) concentrations
of 200 mg/ml or more. One spontaneous mutant and two mutants isolated from mutagenized virus were resistant to PAA
inhibition and showed practically normal viral DNA synthesis in the presence of PAA. DNA polymerase activity present in
the cytoplasmic fraction from cells infected with the mutants required 10-fold higher concentrations of PAA for inhibition
compared to equivalent inhibition of the wild-type enzyme. Like wild-type virus, the PAA-resistant mutants were resistant
to inhibition by aphidicolin. Marker rescue analysis with mutant DNA fragments covering different regions of the ASFV DNA
polymerase gene mapped the mutations within a fragment which was cloned and sequenced. A single nucleotide and amino
acid change was assigned to each mutant. Two of the PAA-resistant mutations lie within the highly conserved region II
common to alpha-like DNA polymerases, which has been implicated in pyrophosphate binding and probably also in dNTP
binding. The other mutation was localized to within a region of moderate homology among viral DNA polymerases close
to one of the motifs allegedly considered as constituting the 3*–5* exonuclease active site. q 1995 Academic Press, Inc.
INTRODUCTION exact role of each motif in the different biochemical steps
involved in DNA synthesis has not been elucidated yet.
African swine fever virus (ASFV) is a large icosahedral
Since DNA polymerase inhibitors can be assigned
DNA virus that replicates in the cytoplasm of infected
specific targets in enzyme active sites, drug-resistant mu-
cells and is the only member of an unnamed family (for
tants are invaluable tools to study the functions of DNA
reviews, see Costa, 1990; Salas, 1994). For cytoplasmic
polymerase and to correlate them to molecular architec-
DNA replication, the virus must encode for a specific
ture. A commonly used inhibitor of viral DNA polymer-
DNA polymerase (Rodrı´guez et al., 1993; Martins et al.,
ases is phosphonoacetic acid (PAA) (Shipkowitz et al.,
1994), which is inhibited by phosphonoacetic acid (Mor-
1973; Bolden et al., 1975; Moreno et al., 1978). PAA is
eno et al., 1978) but resistant to aphidicolin (Marques
thought to inhibit DNA polymerase by competing with
and Costa, 1992). Other interesting features of ASFV-
pyrophosphate binding. So, the molecular identification
specific DNA polymerase are the presence of a repeat
of PAA-resistant mutations can reveal critical amino
array of four amino acid repeat units close to the carboxyl
acids involved in the recognition of pyrophosphate. Her-
end and the ability of the enzyme to catalyze rolling circle
pesvirus and vaccinia virus mutants resistant to PAA or
DNA replication independent of a specific viral origin
to its congener phosphonoformic acid have been iso-(Oliveira and Costa, 1995).
lated (Hay and Subak-Sharpe, 1976; Jofre et al., 1977;ASFV DNA polymerase is a member of family B of DNA
Coen and Schaffer, 1980; Moss and Cooper, 1982; Dersepolymerases, which includes eukaryotic and prokaryotic
et al., 1982; Coen et al., 1982; Sridhar and Condit, 1983;alpha-like DNA polymerases, as well as the DNA poly-
Knopf, 1987; Hwang et al., 1992) and mutations havemerases encoded by poxviruses, herpesviruses, Chlo-
been fine mapped by marker rescue and identified byrella viruses, baculoviruses, and adenoviruses, and the
sequence analysis (Earl et al., 1986; Larder et al., 1987;DNA polymerases that use protein priming (Ito and
Gibbs et al., 1988; Traktman et al., 1989; Hwang et al.,Braithwaite, 1991). These DNA polymerases share sev-
1992).eral conserved motifs that are supposed to play a critical
Marker rescue is based on homologous recombina-role in enzyme activity (Wong et al., 1988). However, the
tion, leading to the production of recombinant drug-resis-
tant virus when cells infected with wild-type virus are
transfected with mutant DNA. Since transfected DNA can1 The nucleotide sequence data reported in this paper have been
submitted to the GenBank nucleotide sequence database and have efficiently recombine in ASFV-infected cells (Rodrı´guez
been assigned Accession Nos. U27573 (PAA100), U27574 (PAA20), and
et al., 1992), marker rescue is an easy approach to mapU27575 (PAA463).
ASFV mutations. We have previously reported the identifi-2 To whom reprint requests should be addressed. Fax:
/351(1)4435625. E-mail: jcosta@gulbenkian.pt. cation of the ASFV gene for the DNA polymerase by
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marker rescue experiments using a PAA-resistant mutant ing the cytoplasmic fraction. This cytoplasmic fraction
was precipitated with TCA and counted.(Martins et al., 1994). In this article, we extend this obser-
vation to other mutants and identify in the gene sequence
the exact amino acid substitutions that confer drug resis- DNA polymerase assay
tance.
Cells were infected at 20 PFU per cell and cytoplasmic
extracts were prepared at 10 hr p.i. as described above.
MATERIALS AND METHODS Reaction mixtures for DNA polymerase assays contained
10 ml cytoplasmic extract from 106 cells, 25 mg activatedVirus and cells
calf thymus DNA, and 2 mCi [32P]dATP (800 Ci/mmol), in
Monkey Vero cells were cultured in Dulbecco’s modi- 100 ml reaction buffer: 50 mM Tris–HCl, pH 7.5, 50 mM
fied Eagle’s medium with 8% newborn calf serum. ASFV, KCl, 10 mM MgCl2 , 1 mM dithiothreitol, 100 mM each
Lisbon-60 isolate adapted to grow in monkey cells, was dCTP, dGTP, and dTTP, and 20 mM dATP. The mixtures
produced and titrated as described (Barros et al., 1986). were incubated for 45 min at 377 and acid-insoluble ra-
dioactivity was counted.
Production of PAA-resistant mutants
DNA preparation and molecular cloning
For the isolation of spontaneous PAA-resistant mu-
tants, Vero cells were infected with 0.5 PFU per cell of Viral DNA was prepared from extracellular virus. The
wild-type African swine fever virus and covered with a virus was concentrated by centrifugation at 6000 g for
0.9% agar overlay containing 0.003% neutral red in me- 16 hr at 47 and treated for 30 min at 377 with 25 mg/ml
dium with 100 mg/ml PAA. Several plaques with normal DNase and 50 mg/ml RNase. EDTA and NaCl were added
size were picked and expanded in the presence of 100 to give final concentrations of 25 mM and 1 M, respec-
mg/ml PAA. They were then plaqued five times in succes- tively, and the virus was centrifuged at 100,000 g for 30
sion in the presence of 200 mg/ml PAA. min at 47 through a cushion of 20% sucrose in 50 mM
ASFV was mutagenized with bromodeoxyuridine or ni- Tris–HCl, pH 7.5, 1 mM EDTA, and 1 M NaCl. The virus
trosoguanidine. Cells were infected with 5 PFU per cell pellet was resuspended in TE (10 mM Tris–HCl, pH 8,
and incubated in the presence of 5 mg/ml of one or the 1 mM EDTA) and viral DNA was extracted by incubation
other mutagen. This dose had been determined in previ- with 500 mg/ml proteinase K and 0.5% SDS for 1 hr at
ous experiments to result in about 90% reduction in virus 607. DNA was then extracted twice with phenol and
yield for each of the drugs. In the case of nitrosoguaidine treated again with proteinase K and SDS for 1 hr at 377.
mutagenization, the medium was replaced at 10 hr p.i. After extraction with phenol–chloroform–isoamyl alco-
with fresh medium without the mutagen. When the cyto- hol and with chloroform–isoamyl alcohol, DNA was pre-
pathic effect in control infected cultures was total, the cipitated with ethanol and dissolved in TE.
medium was harvested and titrated in the presence of Manipulation of DNA, restriction enzyme digestions,
200 mg/ml PAA. Individual plaques were picked, ex- agarose gel electrophoresis, and cloning of mutant DNA
panded, and cloned three times, always in the presence fragments in pBluescript II (SK/) (Stratagene) were per-
of 200 mg/ml PAA. formed following standard methods (Sambrook et al.,
1989).
Measurement of viral DNA synthesis
Marker rescue
Viral DNA replication was assessed by measuring the
incorporation of tritiated thymidine into acid-insoluble Cells were infected with 1 PFU per cell. At 1 hr p.i.,
they were trypsinized, washed, and resuspended in ice-material in the cytoplasm of infected cells. Cells were
infected with 20 PFU per cell. After adsorption, the me- cold transfection buffer (20 mM HEPES–KOH, pH 7.05,
140 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4 , and 5.6 mMdium was replaced with medium containing 2% dialyzed
newborn calf serum. At different times after infection, glucose) at about 106 cells per milliliter. One milliliter
cell suspension was mixed with 10–25 mg mutant DNAcells were pulse-labeled for 15 min with 30 mCi/ml
methyl[3H]thymidine (48 Ci/mmol). At the end of the pulse, recombinants, transferred to a well of an ice-cold 24-well
multidish, and electrotransfected, using a Pro-Genetor2.5 mM unlabeled thymidine was added and the cells
were washed and scraped into ice-cold PBS and resus- (Hoefer Scientific Instruments) at 300 V with six pulses
of 30 msec. The cell suspension was incubated on icepended in RSB (10 mM Tris–HCl, pH 7.5, 10 mM NaCl,
5 mM MgCl2). After addition of 0.5% NP-40, the cells were for another 10 min and plated on 150-mm dishes con-
taining 2 1 106 uninfected cells. PAA was not addedincubated in ice for 15 min. The nuclei were centrifuged
and resuspended in RSB with 150 mM NaCl and 0.1% during infection because it is known that the drug inhibits
marker rescue (Traktman et al., 1989). When cytopathicTriton X-100. The nuclei were centrifuged again and the
supernatant was pooled with the previous one, constitut- effect was complete, extracellular virus was harvested
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5 PFU per cell and PAA was added at different concentra-
tions from the beginning of infection. When cytopathic
effect was complete in control infected cultures to which
no drug was added, extracellular virus was harvested
and titrated in the absence of the inhibitor. At concentra-
tion of 200 mg/ml, PAA addition resulted in a reduction
of more than 4 orders of magnitude in the production of
wild-type virus. This concentration of PAA caused practi-
cally no inhibition of virus growth in cells infected with
any of the virus mutants.
PAA also inhibited plaque formation by wild-type ASFV.
When 100 mg/ml PAA was added to the agar overlay,
wild-type plaque formation was reduced by more than 4
logarithmic orders of magnitude, whereas mutant plaque
formation was reduced by less than 50% (Fig. 2). Besides,
wild-type plaques were much smaller than usual but mu-
tant plaques were of normal size. No plaque was formed
by wild-type virus when PAA was added at concentra-
tions of 200 mg/ml or higher. These concentrations had
FIG. 1. Effect of phosphonoacetic acid (PAA) on virus production by much lower effect on mutant virus plaque formation. At
cells infected with wild-type ASFV and PAA-resistant mutants. Vero
the greatest tested concentration, 300 mg/ml, the ratiocells were infected with 5 PFU per cell and incubated in the presence
between the number of plaques formed by PAA20,of different concentrations of PAA. Extracellular virus was harvested
when the cytopathic effect in infected control plates lacking PAA was PAA100, and PAA463 and the number of plaques in the
complete and was titrated by plaque assay in medium without the absence of the drug, defined as plating efficiency, was
inhibitor. 0.1, 0.14, and 0.02, respectively.
Synthesis of wild-type virus and mutant DNA in the
and titrated in the presence of 300 mg/ml PAA and in the
presence of PAA
absence of the inhibitor.
Viral DNA replication was assessed by measuring the
DNA sequencing incorporation of labeled thymidine into acid-insoluble
material present in the cytoplasmic fraction of cells in-Double-stranded cloned DNA, 1 pmol, was denatured
in 0.2 M NaOH and 2 mM EDTA, neutralized, and precipi-
tated with ethanol. The denatured DNA was used as
template for sequencing by the dideoxy chain termination
method (Sanger et al., 1977), using a Sequenase 2.0 kit
from United States Biochemicals as recommended by
the manufacturer. The sequences of both strands were
determined by using standard M13 primers or specific
primers synthesized on the basis of sequences already
read.
RESULTS
Isolation and characterization of PAA-resistant
mutants
We isolated and analyzed the growth properties of
three PAA-resistant mutants of ASFV. Mutant PAA100
was a spontaneous mutant isolated after infection of
Vero cells with wild-type virus in the presence of PAA.
Mutants PAA20 and PAA463 were selected from virus
stocks mutagenized with bromodeoxyuridine and nitro-
FIG. 2. Inhibition of plaque formation by PAA. Wild-type and mutantsoguanidine, respectively. All the mutants were repeat-
viruses were titrated in the absence or in the presence of different
edly plaque-purified in the presence of 200 mg/ml PAA. concentrations of PAA. Plating efficiency is defined as the ratio between
PAA inhibited the yield of wild-type ASFV during one- the number of plaques formed in the presence and in the absence of
the inhibitor.cycle growth conditions (Fig. 1). Cells were infected with
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cells infected with wild-type virus was considerably in-
hibited when PAA was added to the reaction mixture.
For instance, addition of 100 mg/ml PAA resulted in 94%
reduction in enzymatic activity. DNA polymerase activity
in extracts from cells infected with the mutants was less
sensitive to inhibition, although the differences in enzyme
resistance between the mutant and wild-type viruses
were not as pronounced as the ones described above
for virus production and plaque formation. Equivalent de-
grees of inhibition of wild-type and mutant enzymes re-
quired about 10-fold differences in drug concentration.
Marker rescue with fragments of the DNA
polymerase gene
Work from this laboratory (Martins et al., 1994) has
previously shown that transfection of the EcoRI-H frag-
ment of PAA100 DNA into cells infected with wild-type
virus resulted in the production of mutant virus. This ex-
periment led to the identification and sequencing of theFIG. 3. Time course of viral DNA replication. Cells were infected with
DNA polymerase gene.wild-type virus, in the presence or in the absence of 200 mg/ml PAA,
or with mutant virus in the presence of the same concentration of PAA. We cloned the EcoRI-H fragment of each mutant and
At different times after infection, infected cells were pulse-labeled for prepared sets of subclones for fine mapping of the muta-
15 min with 30 mCi/ml methyl[3H]thymidine and lysed with 0.5% NP-40. tions by marker rescue. A schematic representation of
The nuclei were removed by centrifugation and the cytoplasmic fraction
the subclones is depicted in Fig. 5. The DNA polymerasewas precipitated with TCA and counted.
gene starts at position 205 relative to the unique BamHI
site in the EcoRI-H fragment and extends 90 bases to
fected with wild-type or mutant virus (Fig. 3). Control ex- the right of the EcoRI site. From subclone 1 containing
periments showed that cytoplasmic incorporation in the 3800-nucleotide-long BamHI–EcoRI fragment, we
mock-infected cells was negligible. Cells infected with prepared subclone 2 by excision of a 2066-nucleotide-
wild-type ASFV in the absence of PAA showed a marked long BamHI–NcoI fragment, filling the extremes with
increase in thymidine incorporation, starting between 2 Klenow enzyme and blunt-end ligation. The fragment be-
and 4 hr p.i. and reaching a maximum at 8 hr p.i. Addition
of 200 mg/ml PAA from the beginning of infection resulted
in considerable decrease of incorporation, almost to
background levels. Thymidine incorporation in the cyto-
plasm of cells infected with PAA20 or PAA100 in the
presence of PAA was practically of the same level as in
the absence of the drug, whereas PAA463 DNA synthesis
was reduced by about 40%. Viral DNA replication by cells
infected with PAA100, either in the presence or in the
absence of the inhibitor, seemed to be somewhat faster
than in the case of wild-type virus or the other mutants,
reaching the maximum at 6 hr p.i.
Effect of PAA on wild-type and mutant DNA
polymerases
Since PAA is an inhibitor of DNA polymerase, we can
suppose that PAA-resistant mutations reside in the viral
DNA polymerase gene, coding for resistant enzymes. To
confirm this, we assayed the DNA polymerase activity in
cytoplasmic extracts from cells infected with wild-type
FIG. 4. DNA polymerase activity of cytoplasmic extracts from cellsand mutant viruses. The background of cellular enzy-
infected with wild-type or PAA-resistant mutants. Enzyme assays were
matic activities, as judged from the assay of cytoplasmic performed as described under Materials and Methods. PAA at different
fractions from uninfected cells, was virtually null. As concentrations was added to the reaction mixtures. Data are presented
as a percentage of that obtained without the inhibitor.shown in Fig. 4, DNA polymerase activity in extracts from
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titer in the presence of PAA 2 to 3 logs lower than the
titer in the absence of the drug. Equivalent results were
obtained after transfection of mutant DNA fragment
EcoRI-H or the BamHI–EcoRI fragment that contains the
complete gene with the exception of the last 90 nucleo-
tides. Subclones 2, 3, and 4, containing DNA fragments
mapping to the right of the NcoI site at position 2066
(relative to the BamHI site), gave negative results with
all mutants. Subclone 5 from all the mutants, mapping
from positions 1 to 2712, rescued wild-type virus to the
resistant phenotype. Finer mapping of the PAA20 and
PAA463 mutations between positions 1639 and 2066 was
determined from the positive rescue with subclone 6 and
from the negative results with all the subclones mapping
to the left of the PstI site at position 1639. Different from
the other two mutations, PAA100 was not rescued by
subclone 6. It could be mapped within a short 263-nucle-
otide-long region, between the AccI site at position 1376
and the PstI site at position 1639, since the mutation wasFIG. 5. Identification of the subclones within the DNA polymerase
rescued with subclone 8 but not with subclone 7. Thisgene used for fine mapping of the PAA-resistant mutations by marker
rescue. The position of the gene is indicated by the gray bar. Restriction result was confirmed by rescue with subclone 11.
enzyme sites are abbreviated as follows: A, AccI, B, BamHI; C, ClaI; E,
Sequence analysis of mutant DNA polymerase genesEcoRI; H, HindIII; Hc, HincII; N, NcoI; P, PstI.
Subclone 6 from PAA20 and PAA463 and subclone 11
from PAA100 were sequenced to determine the exacttween the ClaI site of subclone 2 at position 3010 and
lesion in the three mutants. In all cases, both strandsthe ClaI site of the vector was cloned as subclone 4. The
were sequenced and sequences were confirmed by ex-remaining plasmid, after excision of the ClaI fragment
tensive overlapping of the sequenced stretches.and religation, was designated subclone 3. Subclone 5
Figure 6 shows the nucleotide sequence of wild-typecontains a 2712-nucleotide-long BamHI–HincII fragment
DNA polymerase gene (Martins et al., 1994) between theprepared by religation after excision of the fragment de-
HindIII site at position 1023 and the NcoI site at positionlimited by the unique HincII sites in the insert and in the
2066, within which all the mutants map. These coordi-vector. From this subclone 5 we constructed subclone 6
nates are referred to the original published sequence ofby excising the 1597-nucleotide-long PstI fragment be-
the BamHI–EcoRI fragment. The mutations are illustratedtween the sites at positions 42 and 1639, and subclone
in the figure above the wild-type sequence and are7 by excising the 690-nucleotide-long AccI fragment be-
shown enclosed in boxes. All three mutations are pointtween the sites at positions 1376 and 2388. The PstI
mutations, resulting in a single amino acid change.fragment was cloned in pBluescript II (SK/) to generate
PAA100 mutation is an A-to-G transition located at posi-subclone 8. This subclone was digested with HindIII and
tion 1511 of the original wild-type sequence and resultsreligated as subclone 9. The two other HindIII fragments,
in the substitution of a glycine residue for an asparticbetween the sites at positions 573 and 1023, and be-
acid residue. Mutations PAA20 and PAA463 map very
tween the latter site and the site in the vector, were
close, at positions 1748 and 1738, respectively. These
electroeluted from the gel and cloned as subclones 10
positions map within the highly conserved region II of
and 11, respectively.
family B DNA polymerases (Wong et al., 1988), which is
The lesions in the three PAA-resistant mutants were
underlined in Fig. 6. Both mutations were found to be
fine mapped by marker rescue experiments using these
single C-to-T transitions, resulting in the substitution of
subfragments of the mutant DNA polymerase genes to
valine for alanine in mutant PAA20 and of phenylalanine
transfect cells infected with wild-type virus. In control for leucine in mutant PAA463. Secondary structure pre-
experiments, infected cells were transfected with wild- diction, performed by using the programs PepPlot and
type viral DNA, with wild-type DNA EcoRI-H fragment, or PeptideStructure of the Wisconsin package (Devereux et
with pBluescript DNA. In no case were plaques observed al., 1984), did not reveal any significant alteration in the
when virus yields from these infections were titrated in predicted protein structures caused by the amino acid
the presence of PAA. changes in the mutants.
Representative data of marker rescue experiments
DISCUSSIONwith the mutant DNA subclones are shown in Table 1.
With all the mutants, transfection with intact viral DNA DNA polymerization is a complex multistep process
involving coupled reactions and interactions with differ-resulted in the production of PAA-resistant virus, with a
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TABLE 1
Fine Mapping of the PAA-Resistant Mutations by Marker Rescue with Subfragments of the DNA Polymerase Gene
Virus (PFU/ml)b
PAA20 PAA100 PAA463
DNAa 0PAA /PAA 0PAA /PAA 0PAA /PAA
— c 3.9 1 106 0 1.5 1 107 0 6.5 1 106 0
Genomicd 6 1 106 1.3 1 104 1.3 1 107 6.5 1 104 5.3 1 106 1.4 1 104
1 6 1 106 2 1 104 1.3 1 107 8.6 1 104 2.1 1 106 4 1 103
2 6 1 106 0 9 1 106 0 5.5 1 106 0
3 6 1 106 0 1.3 1 107 0 7.5 1 106 0
4 3.3 1 106 0 1.4 1 107 0 8.5 1 106 0
5 5.5 1 106 3.7 1 103 3.5 1 106 1 1 104 8.5 1 106 4.5 1 104
6 3.5 1 106 1.3 1 103 3.5 1 106 0 7.5 1 106 9 1 103
7 3.5 1 106 0 6.5 1 106 0 7 1 106 0
8 3.1 1 106 0 6.5 1 106 1.4 1 104 N.D.e N.D.
9 N.D. N.D. 7 1 106 0 N.D. N.D.
10 N.D. N.D. 6.5 1 106 0 N.D. N.D.
11 N.D. N.D. 9 1 106 1.8 1 104 N.D. N.D.
a DNA used to transfect cells infected with wild-type virus. Numbers 1 to 11 indicate the subclones prepared from mutant DNA EcoRI-H fragment.
The dimensions and coordinates of the subclones are indicated in Fig. 5.
b Cells were infected with wild-type virus and transfected with mutant or control DNA, as described under Materials and Methods. Virus from
the transfected cells was harvested and titrated in the absence (0PAA) and in the presence (/PAA) of 300 mg/ml PAA.
c No DNA was transfected into infected cells.
d Genomic DNA from the virus mutants.
e Not done.
ent nucleotide structures. Mutants that maintain the es- actions or recognition functions are important tools to
elucidate the biochemical mechanisms of DNA polymer-sential features of DNA polymerization but have an al-
tered phenotype directly related to one of the enzyme ase action and to identify critical amino acids. This kind
FIG. 6. Nucleotide sequence of the HindIII–NcoI fragment of wild-type DNA polymerase gene and identification of PAA100 (a), PAA463 (b), and
PAA20 (c) mutations. Nucleotide and amino acid changes are indicated above the wild-type sequence and boxed. The conserved polymerase II
motif (Wong et al., 1988) is underlined.
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of mutant comprises the drug-resistant mutants, since among these regions are involved in the generation of
the pyrophosphate binding site.we can correlate their lesion to the known action of the
PAA is a competitive inhibitor of pyrophosphate in theinhibitors on specific enzyme functions.
pyrophosphate exchange reaction and is a noncompeti-In this report we describe the isolation and character-
tive inhibitor of DNA synthesis with respect to dNTPsization of three PAA-resistant mutants of ASFV. All the
(Leinbach et al., 1976). The affinities for dNTPs of wild-mutants were fully resistant to concentrations of PAA
type and phosphonoformate-resistant DNA polymerasesthat drastically inhibited virus production or completely
of HSV-1 do not follow a pattern that can be correlatedinhibited plaque formation by wild-type virus. The con-
to their sensitivities to the inhibitor (Derse et al., 1982).centration of PAA required for the inhibition of wild-type
These observations might indicate that the recognitionvirus growth was found to be higher than that reported
sites for dNTPs and pyrophosphate are distinct. How-by Moreno et al. (1978) for the Ba71 strain of ASFV and
ever, it has been repeatedly observed that PAA resis-much closer to that needed to inhibit vaccinia virus
tance or hypersensitivity segregate very frequently withgrowth (Moss and Cooper, 1982). This difference be-
altered sensitivity to drugs that are competitive inhibitorstween the two strains of ASFV, like the differences ob-
of dNTP binding, namely, aphidicolin, acyclovir, and ara-served among herpes simplex virus type 1 (HSV-1) iso-
binoside analogs of dNTPs (Coen et al., 1983; Honesslates (Derse et al., 1982), may reflect the selection from
et al., 1984; Nishiyama et al., 1984; Tsurumi et al., 1987;a population of virus normally inducing a variety of DNA
Hall et al., 1989; Matsumoto et al., 1990; Tadie and Trakt-polymerases conserving the basic catalytic functions.
man, 1991). Besides, five purified herpesvirus-inducedThis diversity may be an important adaptive factor and
DNA polymerases resistant to phosphonoformic acid ex-could explain the easiness of isolation of PAA-resistant
hibited decreased affinities for dNTPs (Derse et al., 1982).variants from nonmutagenized viruses (this work; Moss
Therefore, it is probable that the pyrophosphate bindingand Cooper, 1982).
site coincides or partially overlaps the dNTP binding site.Consistent with the well-established fact that PAA
The pyrophosphate binding site might have a role inblocks virus production by inhibiting the viral DNA poly-
recognizing that the nucleotides are in the correct tri-merases, the enzyme activity of cytoplasmic extracts from
phosphate form. Alternatively, as proposed by Derse et
cells infected with the mutants was considerably more
al. (1982), PAA and dNTPs, though binding to different
resistant to PAA inhibition than the activity present in
sites, might have a common inhibitory mechanism, affect-
similar extracts from cells infected with wild-type ASFV.
ing the ability of the enzyme to translocate.
However, the difference between the activities induced
ASFV is fully resistant to aphidicolin (Marques and
by mutant and wild-type viruses was not as pronounced Costa, 1992). Therefore, it was interesting to investigate
as the differences in virus production or plating effi- whether the ASFV mutations conferring resistance to
ciency. Although it is difficult to compare these different PAA also resulted in sensitivity to aphidicolin. As de-
inhibition parameters, it seems that a small level of en- scribed in a previous report (Marques and Costa, 1992),
zyme activity resistant to the inhibitor may be sufficient the DNA polymerase activity induced by the three mu-
for efficient viral DNA synthesis and virus production by tants showed the same resistance to aphidicolin as that
cells infected with mutant virus. induced by wild-type virus. We have now confirmed that
Family B DNA polymerases share seven highly con- aphidicolin does not affect virus production, plating effi-
served regions, designated as regions I to VII (Wong et ciency, or viral DNA synthesis in cells infected with any
al., 1988; Hwang et al., 1992). The high degree of homol- of the PAA-resistant mutants (data not shown). In the
ogy observed in these regions across significant evolu- case of the ASFV mutants, we do not know whether
tionary distances is probably a reflection of functional resistance to PAA is associated with altered affinity for
importance. Drug-resistant mutations lying within these dNTPs. Overexpression and purification of the mutant
conserved regions can provide clues as to their role in enzymes will allow their biochemical characterization.
the enzyme functions targeted by the inhibitors. Two of Sequencing of the PAA100 mutant gene revealed that
the mutants that we have isolated, PAA20 and PAA463, the amino acid change falls within the A region that is
show amino acid substitutions in the conserved region common to herpesvirus and poxvirus DNA polymerases
II. The mutation in PAA20 affects the same amino acid (Gibbs et al., 1988). A comparison of 30 family B DNA
as the one changed in the PAA-resistant and acyclovir- polymerases made by us (Fig. 7) showed that the weak
resistant mutant TP2.4 of HSV-1 (Larder et al., 1987). As homology observed in this region among those viral poly-
shown in Fig. 7, several other herpesvirus and bacterio- merases can be extended to the whole of alpha-like DNA
phage T4 mutants with altered sensitivity to PAA also polymerases. A similar alignment was previously ob-
map within the conserved region II. Other mutants with tained by Braithwaite and Ito (1993). In these two align-
the same phenotype were mapped in regions III, V, and ments, the amino acid change in PAA100 corresponds,
VII (Larder et al., 1987; Gibbs et al., 1988; DeFilippes, at the same position, to the substitutions observed in
the PAA-resistant mutant RSC-26 of HSV-1 (Larder et al.,1989; Hwang et al., 1992), suggesting that interactions
/ m4484$7573 10-24-95 07:46:12 vira AP-Virology
79ASFV PAA-RESISTANT MUTANTS
FIG. 7. Comparison of the amino acid sequences of family B alpha-like DNA polymerases, between the proposed exonuclease motif III (Bernad
et al., 1989) and the highly conserved motif II in the polymerase domain (Wong et al., 1988). Another region of similarity among herpesvirus and
poxvirus DNA polymerases, designated as region A by Gibbs et al. (1988), is also indicated. The sequences of 30 family B DNA polymerases (listed
in Martins et al., 1994) in the region between those motifs were aligned with the program PileUp of the Wisconsin package (Devereux et al., 1984).
The overall alignment was partially corrected by considering the optimal alignments of subsets of more closely related sequences (herpesviruses,
alpha eukaryotic, delta eukaryotic, archeobacterial, protein-primed). Representative examples of these subsets are presented and abbreviated as
follows: HSV1, herpes simplex virus type 1; VV, vaccinia virus; AcNPV, Autographa californica nuclear polyhedrosis virus; ChV, PBCV-1 Chlorella
virus; Hu. d, human DNA polymerase delta; Hu. a, human DNA polymerase alpha; S. so., Sulfolobus solfataricus; T4, bacteriophage T4; Ad2, human
adenovirus type 2; M2, bacteriophage M2; pCLK1, linear plasmid of Claviceps purpurea. White boxes indicate amino acids that are common to at
least two-thirds of all the 30 aligned sequences. The following conservative amino acid substitutions were considered: A and G; S and T; K, R, and
H; D, E, N, and Q; I, L, M, and V; F and Y. Black boxes indicate the amino acids that are changed in ASFV, herpes simplex virus type 1, vaccinia
virus, bacteriophage T4, and bacteriophage M2 mutations conferring altered sensitivity to PAA (Larder et al., 1987; Knopf and Weisshart, 1988;
Matsumoto et al., 1989, 1990; Tadie and Traktman, 1991; Reha-Krantz et al., 1993; this work). Shaded boxes indicate bacteriophage T4 mutations
resulting in the loss of 3*–5* exonucleolytic activity (Reha-Krantz, 1988).
1987) and to the mutation of the PAA-sensitive mutant I and Exo II of bacteriophage f29, but not of region Exo
III. The 3*–5* exonuclease active site is located in thetsM19 of bacteriophage T4 (Reha-Krantz et al., 1993).
Other bacteriophage T4 reported by these authors, HSV- amino-terminal third of the Klenow fragment of polymer-
ase I and forms a domain that is structurally well sepa-1 mutations conferring resistance to phosphonoformic
acid (Knopf and Weisshart, 1988), aphidicolin-resistant rated from the carboxyl-terminal polymerase domain. The
region immediately downstream to the motif Exo III,and PAA-hypersensitive mutations of vaccinia virus (Ta-
die and Traktman, 1991), and aphidicolin-resistant muta- which would correspond to region A of alpha-like poly-
merases, forms with the Exo III motif a single a-helix. Intions of bacteriophages M2 (Matsumoto et al., 1989) and
f29 (Matsumoto et al., 1990) also lie within region A contrast, the prediction of secondary structure of region
A of the viral and bacteriophage T4 DNA polymerases(Fig. 7).
The amino end of region A coincides with the con- favored a structure of b-sheets or turns for that region
(data not shown).served segment Exo III proposed by Bernad et al. (1989)
as integrating the 3*– 5* exonuclease active site. How- Since E. coli polymerase I and family B DNA polymer-
ases show little or no similarity in amino acid sequenceever, it is difficult to imagine how altered sensitivity to
pyrophosphate and/or dNTP analogs could be related to except for short stretches, extrapolation from the x-ray
structure of polymerase I to other polymerases for whichthe exonuclease function. The hypothesis advanced by
Bernad et al. (1989) and the corresponding structural crystallographic information is not available should be
viewed with caution. The clustering in region A of bacte-model for alpha-like DNA polymerases (Blanco et al.,
1991) is based on the weak homology with the regions riophage T4 mutations conferring sensitivity to PAA and
mutations resulting in loss of exonuclease activity (Reha-known to compose the exonuclease active site of Esche-
richia coli polymerase I (Derbyshire et al., 1988) and on Krantz, 1988; Reha-Krantz et al., 1993), along with the
localization of vaccinia virus (Earl et al., 1986; Traktmanthe results of site-directed mutagenesis of regions Exo
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type 1 reveals features of the DNA polymerase dNTP binding site.et al., 1989) and HSV-1 PAA-resistant mutations (Gibbs
Nucleic Acids Res. 17, 9231–9244.et al., 1988) in the region between the Exo II and Exo III
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the exonuclease and polymerase domains in family B altered DNA polymerase activities in infected cells. J. Gen. Virol. 31,
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